190 related articles for article (PubMed ID: 37056937)
1. CXCL14 promotes metastasis of non-small cell lung cancer through ACKR2-depended signaling pathway.
Chang TM; Chiang YC; Lee CW; Lin CM; Fang ML; Chi MC; Liu JF; Kou YR
Int J Biol Sci; 2023; 19(5):1455-1470. PubMed ID: 37056937
[No Abstract] [Full Text] [Related]
2. A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer.
Sjöberg E; Meyrath M; Milde L; Herrera M; Lövrot J; Hägerstrand D; Frings O; Bartish M; Rolny C; Sonnhammer E; Chevigné A; Augsten M; Östman A
Clin Cancer Res; 2019 Jun; 25(12):3702-3717. PubMed ID: 30850359
[TBL] [Abstract][Full Text] [Related]
3. CXCL14 facilitates the growth and metastasis of ovarian carcinoma cells via activation of the Wnt/β-catenin signaling pathway.
Gao LN; Hao M; Liu XH; Zhang L; Dong Y; Zhang YF; He XC
J Ovarian Res; 2021 Nov; 14(1):159. PubMed ID: 34789307
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
6. Expression of CXCL14 and its anticancer role in breast cancer.
Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
[TBL] [Abstract][Full Text] [Related]
7. Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-
Tian HY; Liang Q; Shi Z; Zhao H
Oxid Med Cell Longev; 2022; 2022():7616696. PubMed ID: 35669852
[TBL] [Abstract][Full Text] [Related]
8. A Novel Autocrine CXCL14/ACKR2 Axis: The Achilles' Heel of Cancer Metastasis?
Zhang Q; Zhou N; Wang W; Zhou S
Clin Cancer Res; 2019 Jun; 25(12):3476-3478. PubMed ID: 30952637
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Cao B; Yang Y; Pan Y; Jia Y; Brock MV; Herman JG; Guo M
Discov Med; 2013 Oct; 16(88):137-47. PubMed ID: 24099668
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
11. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Liu MX; Zhou KC; Cao Y
Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
[TBL] [Abstract][Full Text] [Related]
12. CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.
Ji X; Shen Z; Zhao B; Yuan X; Zhu X
Medicine (Baltimore); 2018 Mar; 97(10):e0101. PubMed ID: 29517684
[TBL] [Abstract][Full Text] [Related]
13. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
[TBL] [Abstract][Full Text] [Related]
14. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
[TBL] [Abstract][Full Text] [Related]
15. CXC chemokine ligand-13 promotes metastasis via CXCR5-dependent signaling pathway in non-small cell lung cancer.
Chao CC; Lee WF; Wang SW; Chen PC; Yamamoto A; Chang TM; Weng SL; Liu JF
J Cell Mol Med; 2021 Oct; 25(19):9128-9140. PubMed ID: 34427969
[TBL] [Abstract][Full Text] [Related]
16. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
17. Involvement of CXCL14 in osteolytic bone metastasis from lung cancer.
Takiguchi S; Korenaga N; Inoue K; Sugi E; Kataoka Y; Matsusue K; Futagami K; Li YJ; Kukita T; Teramoto N; Iguchi H
Int J Oncol; 2014 Apr; 44(4):1316-24. PubMed ID: 24534874
[TBL] [Abstract][Full Text] [Related]
18. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB.
Liu W; Wang H; Bai F; Ding L; Huang Y; Lu C; Chen S; Li C; Yue X; Liang X; Ma C; Xu L; Gao L
Cell Prolif; 2020 Mar; 53(3):e12776. PubMed ID: 32020709
[TBL] [Abstract][Full Text] [Related]
19. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
[TBL] [Abstract][Full Text] [Related]
20. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]